Stefano Aliberti is Professor of Respiratory Medicine at the University of Milan and a consultant at the Respiratory Department and Adult Cystic Fibrosis Center at the Policlinico Hospital in Milan, Italy. He is the Director of the Bronchiectasis, Non-Tuberculous Mycobacteria and Primary Ciliary Dyskinesia programs of the Policlinico Hospital. His major clinical and research interests are in both acute and chronic respiratory infections. He has extensive experience in epidemiological and clinical research in pneumonia since the early-2000s when he was working for the Community-Acquired Pneumonia Organization at the Division of Infectious Diseases at the University of Louisville, KY, United States. He has extensively published clinical and translational research papers on community-acquired pneumonia, especially in the field of clinical failure, cardiovascular events, and antimicrobial resistance. He received the Young Researcher Award in Respiratory Infections from the European Respiratory Society for his contribution on community-acquired pneumonia. Over the past 10 years he has been heavily involved in chronic respiratory infections, including bronchiectasis and non-tuberculous mycobacteria. He founded the European Bronchiectasis Registry (EMBARC) and is the Chair of both the Italian Bronchiectasis Registry and the Italian Registry of Pulmonary Non-Tuberculous Mycobacteria. Professor Aliberti has published up to 200 peer-reviewed articles, notably in respiratory infections, over the past 15 years and was part of different international task forces to produce guidelines on bronchiectasis and severe pneumonia, as well as statements on tuberculosis. He is Associate Editor (Chest Infections) for CHEST®. Professor Aliberti has been heavily involved in different international societies over the past decade, including the European Respiratory Society, the American College of Chest Physicians, and the European Cystic Fibrosis Society, in different educational and scientific committees